Optimus Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 14-12-2024
- Paid Up Capital ₹ 1.00 M
as on 14-12-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 242.46%
(FY 2022)
- Profit -4561.43%
(FY 2022)
- Ebitda 2164.66%
(FY 2022)
- Net Worth -801.67%
(FY 2022)
- Total Assets -57.76%
(FY 2022)
About Optimus Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Uma Rao, Anil Khubchandani, and Pagadala Baskarannarayanan serve as directors at the Company.
- CIN/LLPIN
U24110TG2020PTC139669
- Company No.
139669
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Optimus Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Rao  | Director | 09-May-2024 | Current |
| Anil Khubchandani | Director | 26-Jun-2023 | Current |
| Pagadala Baskarannarayanan | Director | 20-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Optimus Life Science.
Optimus Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 242.46% increase. The company also saw a substantial fall in profitability, with a 4561.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 801.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optimus Life Science?
Unlock access to Optimus Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Optimus Drugs Private LimitedActive 21 years 18 daysUma Rao, Anil Khubchandani and 1 more are mutual person
- Optimus Pharma Private LimitedActive 20 years 2 months
Uma Rao, Anil Khubchandani and 1 more are mutual person
Anjan Drug Private LimitedActive 34 years 4 monthsAnil Khubchandani and Pagadala Baskarannarayanan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Optimus Life Science?
Unlock and access historical data on people associated with Optimus Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optimus Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
